Think about the many rare diseases that are essentially ignored, combined they are a problem but alone they do not merit any significant investment.
Only if it involves in patent medicine. A cure or treatment based on out of patent cheap generic medicines, we can't have that.
You can get patents on novel re-applications of existing substances, iirc. So that's not a blocker either. Besides, academic research just simply try out existing off-patent medicines to see if any work.